211 related articles for article (PubMed ID: 33542378)
1. The G127V variant of the prion protein interferes with dimer formation in vitro but not in cellulo.
Sangeetham SB; Engelke AD; Fodor E; Krausz SL; Tatzelt J; Welker E
Sci Rep; 2021 Feb; 11(1):3116. PubMed ID: 33542378
[TBL] [Abstract][Full Text] [Related]
2.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
3. A valine-to-lysine substitution at position 210 induces structural conversion of prion protein into a β-sheet rich oligomer.
Kakuda K; Yamaguchi KI; Kuwata K; Honda R
Biochem Biophys Res Commun; 2018 Nov; 506(1):81-86. PubMed ID: 30336980
[TBL] [Abstract][Full Text] [Related]
4. A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location.
Ferreira NC; Ascari LM; Hughson AG; Cavalheiro GR; Góes CF; Fernandes PN; Hollister JR; da Conceição RA; Silva DS; Souza AMT; Barbosa MLC; Lara FA; Martins RAP; Caughey B; Cordeiro Y
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133563
[TBL] [Abstract][Full Text] [Related]
5. Prion infection: seeded fibrillization or more?
Birkmann E; Riesner D
Prion; 2008; 2(2):67-72. PubMed ID: 19098436
[TBL] [Abstract][Full Text] [Related]
6. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
Hara H; Sakaguchi S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
[TBL] [Abstract][Full Text] [Related]
7. Methionine oxidation within the prion protein.
Bettinger J; Ghaemmaghami S
Prion; 2020 Dec; 14(1):193-205. PubMed ID: 32744136
[TBL] [Abstract][Full Text] [Related]
8. Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.
Groveman BR; Kraus A; Raymond LD; Dolan MA; Anson KJ; Dorward DW; Caughey B
J Biol Chem; 2015 Jan; 290(2):1119-28. PubMed ID: 25416779
[TBL] [Abstract][Full Text] [Related]
9. Conformational diversity in prion protein variants influences intermolecular beta-sheet formation.
Lee S; Antony L; Hartmann R; Knaus KJ; Surewicz K; Surewicz WK; Yee VC
EMBO J; 2010 Jan; 29(1):251-62. PubMed ID: 19927125
[TBL] [Abstract][Full Text] [Related]
10. Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro.
Dong CF; Wang XF; Wang X; Shi S; Wang GR; Shan B; An R; Li XL; Zhang BY; Han J; Dong XP
Med Microbiol Immunol; 2008 Dec; 197(4):361-8. PubMed ID: 18087720
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
12. A naturally occurring variant of the human prion protein completely prevents prion disease.
Asante EA; Smidak M; Grimshaw A; Houghton R; Tomlinson A; Jeelani A; Jakubcova T; Hamdan S; Richard-Londt A; Linehan JM; Brandner S; Alpers M; Whitfield J; Mead S; Wadsworth JD; Collinge J
Nature; 2015 Jun; 522(7557):478-81. PubMed ID: 26061765
[TBL] [Abstract][Full Text] [Related]
13. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
14. Cell Biology Approaches to Studying Prion Diseases.
Priola SA
Methods Mol Biol; 2017; 1658():83-94. PubMed ID: 28861784
[TBL] [Abstract][Full Text] [Related]
15. Differential Accumulation of Misfolded Prion Strains in Natural Hosts of Prion Diseases.
Lambert ZJ; Greenlee JJ; Cassmann ED; West Greenlee MH
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960722
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
17. Dimerization of the cellular prion protein inhibits propagation of scrapie prions.
Engelke AD; Gonsberg A; Thapa S; Jung S; Ulbrich S; Seidel R; Basu S; Multhaup G; Baier M; Engelhard M; Schätzl HM; Winklhofer KF; Tatzelt J
J Biol Chem; 2018 May; 293(21):8020-8031. PubMed ID: 29636413
[TBL] [Abstract][Full Text] [Related]
18. Transition of the prion protein from a structured cellular form (PrP
Baral PK; Yin J; Aguzzi A; James MNG
Protein Sci; 2019 Dec; 28(12):2055-2063. PubMed ID: 31583788
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the complete resistance of the human prion protein mutant G127V to prion disease.
Zheng Z; Zhang M; Wang Y; Ma R; Guo C; Feng L; Wu J; Yao H; Lin D
Sci Rep; 2018 Sep; 8(1):13211. PubMed ID: 30181558
[TBL] [Abstract][Full Text] [Related]
20. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
